Chemotherapy and Recurrence in Breast Cancer

NEJM Group
NEJM Group
9.2 هزار بار بازدید - 6 سال پیش - A genetic assay predicts a
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it is low, but the benefit of chemotherapy for those with a midrange score is unknown. Learn more about this study: https://nej.md/2JkWbEu

Watch more Quick Take videos: http://nej.md/quick-take
6 سال پیش در تاریخ 1397/04/21 منتشر شده است.
9,253 بـار بازدید شده
... بیشتر